Treatment of pharmacotherapy-refractory posttraumatic stress disorder among Cambodian refugees: a pilot study of combination treatment with cognitive-behavior therapy vs sertraline alone

https://doi.org/10.1016/S0005-7967(03)00032-9Get rights and content

Abstract

Cambodian refugees with posttraumatic stress disorder (PTSD) represent a cohort in severe need of treatment, but little information is available to guide treatment choices. We selected a sample of pharmacotherapy-refractory individuals to test the efficacy of combination treatment with sertraline and cognitive-behavior therapy (CBT) for treating PTSD. Participants in this pilot study were ten Khmer-speaking women who had been at a mean age of 22–26 years during the Pol Pot period (1975–1979). These patients were randomly assigned to either sertraline alone or combined treatment. We found that combined treatment offered additional benefit in the range of medium to large effect sizes for PTSD and associated symptoms. Our findings indicate that substantial gains can be achieved by adding CBT to pharmacotherapy for PTSD, and that a program of CBT emphasizing information, exposure, and cognitive-restructuring can be successfully modified for Khmer-speaking refugees.

Introduction

An estimated 1.5 million Cambodians died during the 4-year Pol Pot period due to starvation, overwork, illness, or execution. In addition many survivors were subjected to the constant threat of death, torture, severe physical deprivation, physical and sexual violence, and physical displacement (Mollica, Poole, & Tor, 1998). Accordingly, studies have documented high rates of both PTSD and major depression in these individuals. For example, in a sample of 50 Cambodian refugees in Greensboro, N.C., 86% met criteria for PTSD, and 80% met criteria for depression (Carlson & Rosser-Hogan, 1994).

Few studies have examined treatment outcome for PTSD in Cambodian refugees. Boehnlein, Kinzie, Ben and Fleck (1985) studied 12 patients and reported 42% no longer met criteria for PTSD after one year of open treatment with medication and long-term psychotherapy. Less success was evident in a smaller sample of Cambodian refugees who received longer-term treatment with imipramine and clonidine (Kinzie & Leung, 1989).

Notably absent are investigations using the treatment modalities associated with the highest effect sizes in empirical reviews: cognitive-behavior therapy (CBT, e.g., Foa, Dancu, Hembree, Jaycox, Meadows and Street, 1999, Resick, Nishith, Weaver, Astin and Feuer, 2002) and treatment with serotonin selective antidepressants (for review see Foa, Keane and Friedman, 2000, Otto, Penava, Pollock and Smoller, 1996). Also absent are investigations of strategies for patients who fail initial interventions. The goal of this pilot study was to provide estimates (effect sizes) for the efficacy of sertraline (Brady et al., 2000) compared to sertraline plus CBT for the treatment of PTSD in a sample of Cambodian refugees. This issue was addressed in a sample of patients unique for two reasons: (1) they had failed to respond to initial pharmacotherapy, and (2) they represented a distinct and severely traumatized cultural group living in the United States.

Section snippets

Participants

The study was approved by the Institutional Review Boards at both Massachusetts General Hospital and the North Suffolk Mental Health. Patients provided written consent after a translator read the consent form in Khmer (all participants were illiterate in Khmer and English). Treatment services were provided in Khmer.

Participants had to meet criteria for current PTSD despite ongoing pharmacotherapy as determined by the Structured Clinical Interview for DSM-IV. All patients in this study were

Results

Pretreatment levels of symptom severity and symptom change across treatment are presented in Table 1. Because random assignment did not fully equate groups, we evaluated the impact of treatment by examining differences between groups in the change in symptoms across treatment. Effect sizes (Cohen’s d) comparing differences between groups on these change scores were calculated:d=M(combined treatment)M(sertraline alone)SD (pooled).These effect sizes were indicative of consistent advantages for

Acknowledgements

Work on this project was supported by a grant from Pfizer Pharmaceuticals to Dr. Pollack and a grant from the van Ameringen Foundation for Dr. Hinton’s contributions to this project.

References (14)

  • M.W. Otto et al.

    Cognitive-behavior therapy for patients failing to respond to pharmacotherapy for panic disorder: A clinical case series

    Behaviour Research and Therapy

    (1999)
  • S. Taylor et al.

    How does anxiety sensitivity vary across the anxiety disorders?

    Journal of Anxiety Disorders

    (1992)
  • D.D. Blake et al.

    A clinician rating scale for assessing current and lifetime PTSD: the CAPS-1

    Behavior Therapist

    (1990)
  • J.K. Boehnlein et al.

    One-year follow-up study of posttraumatic stress disorder among survivors of Cambodian concentration camps

    American Journal of Psychiatry

    (1985)
  • K. Brady et al.

    Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial

    Journal of the American Medical Association

    (2000)
  • E.B. Carlson et al.

    Cross-cultural response to trauma: a study of traumatic experiences and posttraumatic symptoms in Cambodian refugees

    Journal of Traumatic Stress

    (1994)
  • E.B. Foa et al.

    A comparison of exposure therapy, stress inoculation training, and their combination for reducing posttraumatic stress disorder in female assault victims

    Journal of Consulting and Clinical Psychology

    (1999)
There are more references available in the full text version of this article.

Cited by (154)

  • Anxiety sensitivity and your clinical practice

    2019, The Clinician's Guide to Anxiety Sensitivity Treatment and Assessment
View all citing articles on Scopus
View full text